<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Podcasts</title>
    <link>https://www.customerinsights.ai/resources/podcasts</link>
    <description>Insightful, forward-looking conversations with industry leaders on experience, innovation, and the future of Life Sciences.</description>
    <language>en</language>
    <pubDate>Wed, 14 Oct 2026 12:55:47 GMT</pubDate>
    <dc:date>2026-10-14T12:55:47Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>Rethinking Market Access in the Age of AI</title>
      <link>https://www.customerinsights.ai/resources/podcasts/rethinking-market-access-in-the-age-of-ai</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://www.customerinsights.ai/resources/podcasts/rethinking-market-access-in-the-age-of-ai" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.customerinsights.ai/hubfs/market-access-podcast.webp" alt="Rethinking Market Access in the Age of AI" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p class="intro-p"&gt;Market Access has moved from a supporting consideration to a major influence on Commercial Performance in Pharma. In this episode, Abhay Jajoo, Rickey Mehta, and Geoff Woodall trace that evolution—from a 1990s model dominated by Salesforce activity, to the rise of Marketing Mix and Digital Engagement, and ultimately to an environment where Payer Control, Formulary Restrictions, Pricing, Reimbursement, and Access Strategy can materially shape Brand Performance.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://www.customerinsights.ai/resources/podcasts/rethinking-market-access-in-the-age-of-ai" title="" class="hs-featured-image-link"&gt; &lt;img src="https://www.customerinsights.ai/hubfs/market-access-podcast.webp" alt="Rethinking Market Access in the Age of AI" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p class="intro-p"&gt;Market Access has moved from a supporting consideration to a major influence on Commercial Performance in Pharma. In this episode, Abhay Jajoo, Rickey Mehta, and Geoff Woodall trace that evolution—from a 1990s model dominated by Salesforce activity, to the rise of Marketing Mix and Digital Engagement, and ultimately to an environment where Payer Control, Formulary Restrictions, Pricing, Reimbursement, and Access Strategy can materially shape Brand Performance.&lt;/p&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=43629610&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fwww.customerinsights.ai%2Fresources%2Fpodcasts%2Frethinking-market-access-in-the-age-of-ai&amp;amp;bu=https%253A%252F%252Fwww.customerinsights.ai%252Fresources%252Fpodcasts&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Episode 1</category>
      <pubDate>Wed, 16 Sep 2026 13:20:12 GMT</pubDate>
      <guid>https://www.customerinsights.ai/resources/podcasts/rethinking-market-access-in-the-age-of-ai</guid>
      <dc:date>2026-09-16T13:20:12Z</dc:date>
      <dc:creator>CustomerInsights.AI</dc:creator>
    </item>
  </channel>
</rss>
